News
Cabenuva HIV Drug From GlaxoSmithKline Gets FDA Approval
Last year, GlaxoSmithKline’s ViiV Healthcare’s feat of getting a long-awaited approval of HIV treatment by the name of Cabenuva was regarded as a peerless achievement since it eradicated the burden of taking a pill everyday. Another nod a year later...
News
In GSK Patent Settlement, Gilead To Pay $1.25B On Biktarvy
It doesn’t come as a shock when we hear that GlaxoSmithKline and Gilead Sciences are fighting out in HIV domain for a long time, just hoping for an access to success over the other, be it new launches or...
Drug Research
Biogen Exercises Option to Participate in the Development and Commercialization of a Late-Stage Bispecific Antibody
Biogen Inc. announced that it exercised its option to participate in the development and commercialization of mosunetuzumab. Biogen will pay a $30 million one-time option fee to Genentech, a member of the Roche Group, as part of the companies’...
Drug Research
Antiverse collaborates with a top 20 pharma company to identify antibody drug candidates using AI Augmented Drug Discovery platform
Antiverse, a biotechnology company developing a computational antibody drug discovery platform, announced a partnership with a top 20 pharma company with core competencies in the life science fields of health care and nutrition. The collaboration has been successful in...
News
Coriolis Pharma opens new ATMP formulation development facilities
Coriolis Pharma, a globally operating service provider and one of the world leaders in formulation research and development of biopharmaceuticals and vaccines, announced the opening of its new ATMP development facilities under biosafety level S2 (BSL2 / S2).
After one...
News
Pfizer and BioNTech Initiate Rolling Submission for EUA of Their COVID-19 Vaccine in Children 6 Months Through 4 Years of Age Following Request From...
Pfizer Inc. and BioNTech SE announced that following a request from the U.S. FDA the companies have initiated a rolling submission seeking to amend the Emergency Use Authorization (EUA) of the Pfizer-BioNTech COVID-19 Vaccine to include children 6 months...
News
Britain To Finally Vaccinate 5-11 Year Old’s Against COVID
Britain has already been slow to vaccinate its 5-11 year olds, and they are now not vaccinating them as widely as the United States or Israel. NHS England has confirmed that children in the high-risk group will be the...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read